# TBX2

## Overview
TBX2 is a gene that encodes the T-box transcription factor 2, a member of the T-box family of transcription factors, which are characterized by a conserved DNA-binding domain known as the T-box. This protein functions primarily as a transcriptional repressor, although it can also act as an activator in certain cellular contexts. TBX2 plays a crucial role in embryonic development, cell differentiation, and the regulation of cell cycle progression. It is involved in various developmental processes, including heart, limb, and eye development, and is expressed in multiple tissues such as the kidney, lung, and spleen. The protein's activity is modulated by its interactions with chromatin remodeling complexes and other proteins, which influence its role in transcriptional repression. Mutations in the TBX2 gene have been linked to developmental disorders affecting the cardiovascular and skeletal systems, underscoring its importance in normal physiological development (Radio2010TBX2; Liu2018Functional; Abrahams2009The).

## Structure
The TBX2 protein is a member of the T-box family of transcription factors, characterized by a conserved DNA-binding domain known as the T-box, which spans amino acids 106-289 (Abrahams2009The). This domain allows TBX2 to bind specific DNA sequences, such as GTGTGA, GGGTGA, or GTGTTA, functioning primarily as a transcriptional repressor (Abrahams2009The). The human TBX2 protein consists of 712 amino acids (Abrahams2009The).

In terms of secondary structure, the TBX2 protein includes several alpha helices and loops. A specific nonsense mutation (c.529A>T; p.Lys177*) results in structural changes where the α2 and α3 regions are fused into a single α2 region, the α7 region is converted into a loop, and the loop between α7 and α8 is transformed into a helix (Rafeeq2023Case). The α11 region is extended from Lys166 to Ala175 in the mutated form (Rafeeq2023Case).

TBX2 interacts with various components of the NuRD chromatin remodeling complex, including HDAC1, HDAC2, and CHD4, which are crucial for its role in transcriptional repression (Lüdtke2021Combined). These interactions suggest a complex regulatory role, although specific details on quaternary structure are not provided.

## Function
TBX2 is a transcription factor that plays a significant role in various molecular processes in healthy human cells. It is part of the T-box family of transcription factors, which are crucial for embryonic development and cell differentiation. TBX2 functions primarily as a transcriptional repressor, although it can also act as an activator depending on the cellular context (Abrahams2009The). It is involved in regulating cell cycle progression and has been implicated in the suppression of cellular senescence, a process that acts as a barrier to cancer development (Martin2011Physical; Abrahams2009The).

TBX2 is expressed in various tissues, including the kidney, lung, ovary, prostate, spleen, and testis, and plays a role in the development and maintenance of these tissues (Law1995Identification). It is involved in the regulation of genes crucial for heart development, such as Nppa, Cx40, and Cx43, by repressing their expression to facilitate the formation of non-chamber myocardium (Abrahams2009The). TBX2 also interacts with signaling pathways like BMP, influencing processes such as limb and eye development (Abrahams2009The). Its activity is regulated by subcellular localization, with phosphorylation events affecting its nuclear presence (Abrahams2009The).

## Clinical Significance
Mutations and alterations in the TBX2 gene are associated with a range of developmental disorders, particularly affecting the cardiovascular and skeletal systems. A duplication of the TBX2 gene has been linked to complex heart defects and skeletal malformations, including mild mental retardation and digital anomalies, suggesting that overexpression of TBX2 can lead to these clinical features (Radio2010TBX2). Conversely, loss-of-function mutations in TBX2, such as a nonsense variant in the DNA-binding domain, have been associated with severe osteochondrodysplasia, characterized by skeletal abnormalities like widened metaphysis and limb shortening (Rafeeq2023Case).

TBX2 variants have also been implicated in a syndromic cardiovascular and skeletal developmental disorder. Specific missense variants, such as p.R20Q and p.R305H, result in diminished transcriptional repressor function, leading to defects in cardiac and skeletal development (Liu2018Functional). These variants are associated with a range of symptoms, including congenital heart defects, skeletal abnormalities, and developmental delays (Liu2018Functional). The TBX2 gene's role in these disorders highlights its critical function in embryonic development and the potential consequences of its dysregulation.

## Interactions
TBX2, a T-box transcription factor, is involved in various protein interactions that play a crucial role in transcriptional repression and cellular processes. In the developing lung, TBX2 interacts with components of the NuRD complex, including HDAC1, HDAC2, and CHD4, which are essential for chromatin remodeling and transcriptional repression. These interactions help TBX2 repress target genes such as Cdkn1a and Cdkn1b, contributing to lung mesenchyme development (Lüdtke2021Combined). TBX2 also binds to other proteins like PBX1, HMGB2, and CBX3, which are implicated in transcriptional repression (Lüdtke2021Combined).

In breast cancer, TBX2 interacts with the CoREST complex, including components like ZNF217, LSD1, and HDAC1, to repress tumor suppressor genes and sustain cancer cell proliferation. This interaction is significant for the repression of genes such as NDRG1, with TBX2 recruiting the CoREST complex to target regions (McIntyre2022TBX2). The interaction with LSD1 is particularly noteworthy, as it is crucial for the growth of TBX2-dependent breast cancer cells (McIntyre2022TBX2).

These interactions highlight TBX2's role as a transcriptional repressor, influencing gene expression through its association with various protein complexes in different tissue contexts.


## References


[1. (Law1995Identification) D. J. Law, T. Gebuhr, N. Garvey, S. I. Agulnik, and L. M. Silver. Identification, characterization, and localization to chromosome 17q21-22 of the human tbx2 homolog, member of a conserved developmental gene family. Mammalian Genome, 6(11):793–797, November 1995. URL: http://dx.doi.org/10.1007/BF00539006, doi:10.1007/bf00539006. This article has 65 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/BF00539006)

[2. (Abrahams2009The) Amaal Abrahams, M. Iqbal Parker, and Sharon Prince. The t‐box transcription factor tbx2: its role in development and possible implication in cancer. IUBMB Life, 62(2):92–102, December 2009. URL: http://dx.doi.org/10.1002/iub.275, doi:10.1002/iub.275. This article has 83 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/iub.275)

[3. (Liu2018Functional) Ning Liu, Kelly Schoch, Xi Luo, Loren D M Pena, Venkata Hemanjani Bhavana, Mary K Kukolich, Sarah Stringer, Zöe Powis, Kelly Radtke, Cameron Mroske, Kristen L Deak, Marie T McDonald, Allyn McConkie-Rosell, M Louise Markert, Peter G Kranz, Nicholas Stong, Anna C Need, David Bick, Michelle D Amaral, Elizabeth A Worthey, Shawn Levy, Michael F Wangler, Hugo J Bellen, Vandana Shashi, and Shinya Yamamoto. Functional variants in tbx2 are associated with a syndromic cardiovascular and skeletal developmental disorder. Human Molecular Genetics, 27(14):2454–2465, May 2018. URL: http://dx.doi.org/10.1093/hmg/ddy146, doi:10.1093/hmg/ddy146. This article has 55 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddy146)

[4. (Martin2011Physical) Nadine Martin, Moussa Benhamed, Karim Nacerddine, Maud D Demarque, Maarten van Lohuizen, Anne Dejean, and Oliver Bischof. Physical and functional interaction between pml and tbx2 in the establishment of cellular senescence: induction of senescence by a pml-tbx2 synergy. The EMBO Journal, 31(1):95–109, October 2011. URL: http://dx.doi.org/10.1038/emboj.2011.370, doi:10.1038/emboj.2011.370. This article has 31 citations.](https://doi.org/10.1038/emboj.2011.370)

[5. (Radio2010TBX2) Francesca Clementina Radio, Laura Bernardini, Sara Loddo, Irene Bottillo, Antonio Novelli, Rita Mingarelli, and Bruno Dallapiccola. Tbx2 gene duplication associated with complex heart defect and skeletal malformations. American Journal of Medical Genetics Part A, 152A(8):2061–2066, July 2010. URL: http://dx.doi.org/10.1002/ajmg.a.33506, doi:10.1002/ajmg.a.33506. This article has 21 citations.](https://doi.org/10.1002/ajmg.a.33506)

[6. (Lüdtke2021Combined) Timo H. Lüdtke, Irina Wojahn, Marc-Jens Kleppa, Jasper Schierstaedt, Vincent M. Christoffels, Patrick Künzler, and Andreas Kispert. Combined genomic and proteomic approaches reveal dna binding sites and interaction partners of tbx2 in the developing lung. Respiratory Research, March 2021. URL: http://dx.doi.org/10.1186/s12931-021-01679-y, doi:10.1186/s12931-021-01679-y. This article has 13 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s12931-021-01679-y)

[7. (Rafeeq2023Case) Misbahuddin M. Rafeeq, Hussam Aly Sayed Murad, Najumuddin, Samee Ullah, Zaheer Ahmed, Qamre Alam, Muhammad Bilal, Alaa Hamed Habib, Ziaullah M. Sain, Muhammad Jawad Khan, and Muhammad Umair. Case report: a novel de novo loss of function variant in the dna-binding domain of tbx2 causes severe osteochondrodysplasia. Frontiers in Genetics, January 2023. URL: http://dx.doi.org/10.3389/fgene.2022.1117500, doi:10.3389/fgene.2022.1117500. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2022.1117500)

[8. (McIntyre2022TBX2) Alexander J McIntyre, Charlotte Z Angel, James S Smith, Amy Templeman, Katherine Beattie, Shannon Beattie, Alice Ormrod, Eadaoin Devlin, Charles McGreevy, Chloe Bothwell, Sharon L Eddie, Niamh E Buckley, Rich Williams, and Paul B Mullan. Tbx2 acts as a potent transcriptional silencer of tumour suppressor genes through interaction with the corest complex to sustain the proliferation of breast cancers. Nucleic Acids Research, 50(11):6154–6173, June 2022. URL: http://dx.doi.org/10.1093/nar/gkac494, doi:10.1093/nar/gkac494. This article has 5 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkac494)